Aktivacija ovog receptora može da uzrokuje apoptozu.[3] 3E farmakofor model sigma2 receptora baziran na seriji supstituisanih benzo[d]oksazol-2(3H)-on derivata je objavljen.[4]
^Skuza G, Rogóz Z (2006). „The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats”. J. Physiol. Pharmacol. 57 (2): 217—29. PMID16845227.
^Cassano G; Gasparre G; Contino M; et al. (2006). „The sigma-2 receptor agonist PB28 inhibits calcium release from the endoplasmic reticulum of SK-N-SH neuroblastoma cells”. Cell Calcium. 40 (1): 23—8. PMID16687172. doi:10.1016/j.ceca.2006.03.004.CS1 одржавање: Експлицитна употреба et al. (веза)
^Laurini E, Zampieri D, Mamolo MG, Vio L, Zanette C, Florio C, Posocco P, Fermeglia M, Pricl S (2010). „A 3D-pharmacophore model for sigma2 receptors based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives”. Bioorg. Med. Chem. Lett. 20 (9): 2954—7. PMID20347592. doi:10.1016/j.bmcl.2010.03.009.